Microglial phenotype: is the commitment reversible?

Block, 2005, Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism, Prog. Neurobiol., 76, 77, 10.1016/j.pneurobio.2005.06.004 Ladeby, 2005, Microglial cell population dynamics in the injured adult central nervous system, Brain Res. Rev., 48, 196, 10.1016/j.brainresrev.2004.12.009 Minghetti, 2005, Role of inflammation in neurodegenerative diseases, Curr. Opin. Neurol., 18, 315, 10.1097/01.wco.0000169752.54191.97 Sapp, 2001, Early and progressive accumulation of reactive microglia in the Huntington disease brain, J. Neuropathol. Exp. Neurol., 60, 161, 10.1093/jnen/60.2.161 Sargsyan, 2005, Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis, Glia, 51, 241, 10.1002/glia.20210 Streit, 2004, Microglia and Alzheimer's disease pathogenesis, J. Neurosci. Res., 77, 1, 10.1002/jnr.20093 Wang, 2005, MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration, FASEB J., 19, 1134, 10.1096/fj.04-2457fje Weydt, 2004, Increased cytotoxic potential of microglia from ALS-transgenic mice, Glia, 48, 179, 10.1002/glia.20062 Butovsky, 2005, Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective, Mol. Cell. Neurosci., 29, 381, 10.1016/j.mcn.2005.03.005 Hanisch, 2002, Microglia as a source and target of cytokines, Glia, 40, 140, 10.1002/glia.10161 Streit, 2002, Microglia as neuroprotective, immunocompetent cells of the CNS, Glia, 40, 133, 10.1002/glia.10154 Streit, 2005, Microglia and neuroprotection: implications for Alzheimer's disease, Brain Res. Rev., 48, 234, 10.1016/j.brainresrev.2004.12.013 Butovsky, 2001, Morphological aspects of spinal cord autoimmune neuroprotection: colocalization of T cells with B7-2 (CD86) and prevention of cyst formation, FASEB J., 15, 1065, 10.1096/fj.00-0550fje Shaked, 2004, Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system, J. Neuroimmunol., 146, 84, 10.1016/j.jneuroim.2003.10.049 Shaked, 2005, Protective autoimmunity: interferon-γ enables microglia to remove glutamate without evoking inflammatory mediators, J. Neurochem., 92, 997, 10.1111/j.1471-4159.2004.02954.x Streit, 2004, Dystrophic microglia in the aging human brain, Glia, 45, 208, 10.1002/glia.10319 Ma, 2003, Microglia density decreases with age in a mouse model of Huntington's disease, Glia, 43, 274, 10.1002/glia.10261 Carson, 2002, Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis, Glia, 40, 218, 10.1002/glia.10145 van Rossum, 2004, Microglia, Metab. Brain Dis., 19, 393, 10.1023/B:MEBR.0000043984.73063.d8 Schwartz, 2003, Protective autoimmunity against the enemy within: fighting glutamate toxicity, Trends Neurosci., 26, 297, 10.1016/S0166-2236(03)00126-7 Lotan, 1994, Cross talk between the immune system and the nervous system in response to injury: implications for regeneration, FASEB J., 8, 1026, 10.1096/fasebj.8.13.7926367 Carlson, 1998, Acute inflammatory response in spinal cord following impact injury, Exp. Neurol., 151, 77, 10.1006/exnr.1998.6785 Constantini, 1994, The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats, J. Neurosurg., 80, 97, 10.3171/jns.1994.80.1.0097 Dusart, 1994, Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord, Eur. J. Neurosci., 6, 712, 10.1111/j.1460-9568.1994.tb00983.x Fitch, 1999, Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma, J. Neurosci., 19, 8182, 10.1523/JNEUROSCI.19-19-08182.1999 Ghirnikar, 2001, Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat, J. Neurosci. Res., 64, 582, 10.1002/jnr.1110 Mautes, 2000, Vascular events after spinal cord injury: contribution to secondary pathogenesis, Phys. Ther., 80, 673, 10.1093/ptj/80.7.673 Popovich, 1999, Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury, Exp. Neurol., 158, 351, 10.1006/exnr.1999.7118 Hauben, 2001, Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease, J. Clin. Invest., 108, 591, 10.1172/JCI12837 Kipnis, 2004, Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration, J. Neurosci., 24, 6133, 10.1523/JNEUROSCI.0600-04.2004 Moalem, 1999, Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy, Nat. Med., 5, 49, 10.1038/4734 Muhallab, 2002, Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis, Scand. J. Immunol., 55, 264, 10.1046/j.0300-9475.2002.01038.x Rapalino, 1998, Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats, Nat. Med., 4, 814, 10.1038/nm0798-814 Hammarberg, 2000, Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells, J. Neurosci., 20, 5283, 10.1523/JNEUROSCI.20-14-05283.2000 Kipnis, 2000, T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies, Proc. Natl. Acad. Sci. U. S. A., 97, 7446, 10.1073/pnas.97.13.7446 David, 1990, Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system, Neuron, 5, 463, 10.1016/0896-6273(90)90085-T Ousman, 2001, MIP-1α, MCP-1, GM-CSF, and TNF-α control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord, J. Neurosci., 21, 4649, 10.1523/JNEUROSCI.21-13-04649.2001 Hauben, 2000, Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion, J. Neurosci., 20, 6421, 10.1523/JNEUROSCI.20-17-06421.2000 Hauben, 2000, Autoimmune T cells as potential neuroprotective therapy for spinal cord injury, Lancet, 355, 286, 10.1016/S0140-6736(99)05140-5 Zhang, 1996, Genetic influences on cellular reactions to spinal cord injury: a wound-healing response present in normal mice is impaired in mice carrying a mutation (Wlds) that causes delayed Wallerian degeneration, J. Comp. Neurol., 371, 485, 10.1002/(SICI)1096-9861(19960729)371:3<485::AID-CNE10>3.0.CO;2-I Yagihashi, 2005, Macrophage colony stimulating factor (M-CSF) protects spiral ganglion neurons following auditory nerve injury: morphological and functional evidence, Exp. Neurol., 192, 167, 10.1016/j.expneurol.2004.10.020 Byram, 2004, CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation, J. Neurosci., 24, 4333, 10.1523/JNEUROSCI.5276-03.2004 Zhang, 1997, Experimental analysis of progressive necrosis after spinal cord trauma in the rat: etiological role of the inflammatory response, Exp. Neurol., 143, 141, 10.1006/exnr.1996.6355 Bethea, 1999, Systemically administered interleukin-10 reduces tumor necrosis factor-α production and significantly improves functional recovery following traumatic spinal cord injury in rats, J. Neurotrauma, 16, 851, 10.1089/neu.1999.16.851 Kim, 2001, Tumor necrosis factor receptor deletion reduces nuclear factor-κB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury, J. Neurosci., 21, 6617, 10.1523/JNEUROSCI.21-17-06617.2001 Mason, 2001, Interleukin-1β promotes repair of the CNS, J. Neurosci., 21, 7046, 10.1523/JNEUROSCI.21-18-07046.2001 Streit, 2000, Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukinn-6 in neuron–glia signaling during regeneration, J. Neurosci. Res., 61, 10, 10.1002/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E Schwartz, 2002, Differing views on spinal cord repair, Science, 296, 1400, 10.1126/science.296.5572.1400b Fisher, 2001, Increased post-traumatic survival of neurons in IL-6-knockout mice on a background of EAE susceptibility, J. Neuroimmunol., 119, 1, 10.1016/S0165-5728(01)00342-3 Kipnis, 2001, Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response, J. Neurosci., 21, 4564, 10.1523/JNEUROSCI.21-13-04564.2001 Schori, 2001, Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma, Proc. Natl. Acad. Sci. U. S. A., 98, 3398, 10.1073/pnas.041609498 Schori, 2001, T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous system, J. Neuroimmunol., 119, 199, 10.1016/S0165-5728(01)00358-7 Yoles, 2001, Protective autoimmunity is a physiological response to CNS trauma, J. Neurosci., 21, 3740, 10.1523/JNEUROSCI.21-11-03740.2001 Avidan, 2004, Vaccination with autoantigen protects against aggregated β-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells, Eur. J. Immunol., 34, 3434, 10.1002/eji.200424883 Bakalash, 2003, Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma, Invest. Ophthalmol. Vis. Sci., 44, 3374, 10.1167/iovs.03-0080 Fisher, 2001, Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies, J. Neurosci., 21, 136, 10.1523/JNEUROSCI.21-01-00136.2001 Hauben, 2001, Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens, Proc. Natl. Acad. Sci. U. S. A., 98, 15173, 10.1073/pnas.011585298 Kipnis, J. et al. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J. Neuroimmunol. (in press) Mizrahi, 2002, The tissue-specific self-pathogen is the protective self-antigen: the case of uveitis, J. Immunol., 169, 5971, 10.4049/jimmunol.169.10.5971 Olsson, 2005, Genetic dissection of neurodegeneration and CNS inflammation, J. Neurol. Sci., 233, 99, 10.1016/j.jns.2005.03.020 Häusler, 2002, Interferon-γ differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages, Eur. J. Neurosci., 16, 2113, 10.1046/j.1460-9568.2002.02287.x Hsieh, 2004, IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes, J. Cell Biol., 164, 111, 10.1083/jcb.200308101 Aberg, 2003, IGF-I has a direct proliferative effect in adult hippocampal progenitor cells, Mol. Cell. Neurosci., 24, 23, 10.1016/S1044-7431(03)00082-4 O'Kusky, 2000, Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development, J. Neurosci., 20, 8435, 10.1523/JNEUROSCI.20-22-08435.2000 Aberg, 2000, Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus, J. Neurosci., 20, 2896, 10.1523/JNEUROSCI.20-08-02896.2000 Carson, 1993, Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice, Neuron, 10, 729, 10.1016/0896-6273(93)90173-O Shen, 2004, Tumor necrosis factor α inhibits insulin-like growth factor I-induced hematopoietic cell survival and proliferation, Endocrinology, 145, 3101, 10.1210/en.2004-0246 Lichtenwalner, 2001, Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis, Neuroscience, 107, 603, 10.1016/S0306-4522(01)00378-5 Butovsky, O. et al. Microglia activated by IL-4- or IFN-γ differently induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neurosci. (in press) Bernardino, 2005, Modulator effects of interleukin-1β and tumor necrosis factor-α on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures, J. Neurosci., 25, 6734, 10.1523/JNEUROSCI.1510-05.2005 Kitamura, 2005, Recovery of focal brain ischemia-induced behavioral dysfunction by intracerebroventricular injection of microglia, J. Pharmacol. Sci., 97, 289, 10.1254/jphs.SC0040129 Duffield, 2003, The inflammatory macrophage: a story of Jekyll and Hyde, Clin. Sci. (Lond.), 104, 27, 10.1042/CS20020240 Gordon, 2003, Alternative activation of macrophages, Nat. Rev. Immunol., 3, 23, 10.1038/nri978 Ma, 2003, Regulation of macrophage activation, Cell. Mol. Life Sci., 60, 2334, 10.1007/s00018-003-3020-0 Mosser, 2003, The many faces of macrophage activation, J. Leukoc. Biol., 73, 209, 10.1189/jlb.0602325 Stein, 1992, Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation, J. Exp. Med., 176, 287, 10.1084/jem.176.1.287 Hanisch, 2001, The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls, Eur. J. Immunol., 31, 2104, 10.1002/1521-4141(200107)31:7<2104::AID-IMMU2104>3.0.CO;2-3